Frontiers in Lichen Planopilaris and Frontal Fibrosing Alopecia Research: Pathobiology Progress and Translational Horizons.

Senna, Maryanne Makredes; Peterson, Erik; Jozic, Ivan; Chéret, Jérémy; Paus, Ralf

Senna, Maryanne Makredes; Peterson, Erik; Jozic, Ivan; Chéret, Jérémy; Paus, Ralf.

Afiliación

Senna MM; Department of Dermatology, Massachusetts General Hospital, Boston, Massachusetts, USA.
Peterson E; Harvard Medical School, Boston, Massachusetts, USA.
Jozic I; Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery, Miller School of Medicine, University of Miami, Miami, Florida, USA.
Chéret J; Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery, Miller School of Medicine, University of Miami, Miami, Florida, USA.
Paus R; Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery, Miller School of Medicine, University of Miami, Miami, Florida, USA.

JID Innov ; 2(3): 100113, 2022 May.

Article en En | MEDLINE | ID: mdl-35521043

Palabras clave

5ARI, 5α-reductase inhibitor; AA, alopecia areata; AGA, androgenetic alopecia; CRH, corticotropin-releasing hormone; EMT, epithelialâmesenchymal transition; FFA, frontal fibrosing alopecia; HF, hair follicle; IP, immune privilege; K, keratin; KC, keratinocyte; LPP, lichen planopilaris; MAC, macrophage; MHC, major histocompatibility complex; PCA, primary cicatricial alopecia; PCP, personal care product; PPAR-Î³, peroxisome proliferatoractivated receptor-Î³; SC, stem cell; SP, substance P; eHFSC, epithelial hair follicle stem cell; α-MSH, α-melanocyte-stimulating hormone

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: JID Innov Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google